SNOA · Sonoma Pharmaceuticals, Inc. · Proposed Sales
Market Cap
$5.51M
Shares
4.79M
Volume · Oct 21
12.84K
Avg daily vol (3M)
105.18K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-01-03 | Gottfurcht Grant | 10% Stockholder | 86,111 | 2025-01-03 | Merrill Lynch |
| 2025-01-02 | Gottfurcht Grant | Open Market | 30,000 | 2025-01-02 | Merrill Lynch |
| 2025-01-02 | Gottfurcht Grant | Open Market Purchase | 17,806 | 2024-12-31 | Merrill Lynch |
| 2024-12-26 | Gottfurcht Grant | 10% Stockholder | 221,375 | 2024-08-09 | Merrill Lynch |
Showing 1–4 of 4 filings